FDA Adverse Event Malfunction Summary report: N

COBAS 8000 C 702 MODULE

MDR report key: 11687283 · Received April 19, 2021

Report

Report Number
1823260-2021-01185
Event Type
Malfunction
Date Received
April 19, 2021
Date of Event
March 24, 2021
Report Date
April 19, 2021
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER REPLACED THE ENTIRE TUBING OF THE REACTION CELL RINSE STATIONS AND PERFORMED CHECKS. THE INVESTIGATION DETERMINED THE SERVICE ACTIONS RESOLVED THE ISSUE. THIS EVENT OCCURRED IN GBR. (B)(4).

Description of Event or Problem · 1

THE INITIAL REPORTER RECEIVED QUESTIONABLE CA2 CALCIUM GEN.2 AND CREP2 CREATININE PLUS VER.2 RESULTS FOR TWO PATIENTS WITH THE COBAS 8000 C702 MODULE. ON (B)(6) 2021, PATIENT 1 INITIAL CREA2 RESULT WAS 1849 UMOL/L. THE REPEATED RESULT WAS 56 UMOL/L. ON (B)(6) 2021, PATIENT 2 INITIAL CA2 RESULT WAS 1.4 MMOL/L. THE REPEATED RESULT WAS 2.31 MMOL/L. THE QUESTIONABLE RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY. THE REAGENT LOT NUMBERS AND EXPIRATION DATES WERE REQUESTED BUT NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
582017 COBAS 8000 C 702 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS C702 NA

Patients

Seq Age Sex Outcome Treatment
1